Sarepta Therapeutics (SRPT) Revenue (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.63% |
| Dec 31, 2025 | 10.91% |
| Sep 30, 2025 | -34.65% |
| Jun 30, 2025 | 358.32% |
| Mar 31, 2025 | -79.75% |
| Dec 31, 2024 | 40.94% |
| Sep 30, 2024 | 28.72% |
| Jun 30, 2024 | -12.22% |
| Mar 31, 2024 | -10.80% |
| Dec 31, 2023 | 39.69% |
| Sep 30, 2023 | 1,391.31% |
| Jun 30, 2023 | -91.22% |
| Mar 31, 2023 | 49.84% |
| Dec 31, 2022 | -18.57% |
| Sep 30, 2022 | -1.62% |
| Jun 30, 2022 | 859.78% |
| Mar 31, 2022 | -80.35% |
| Dec 31, 2021 | -40.88% |
| Sep 30, 2021 | 33.54% |
| Jun 30, 2021 | -3.47% |
| Mar 31, 2021 | 553.20% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | -13.54% |
| Jun 30, 2020 | 96.73% |
| Mar 31, 2020 | -86.79% |
| Dec 31, 2019 | 1.08% |
| Sep 30, 2019 | 4.62% |
| Jun 30, 2019 | 8.80% |
| Mar 31, 2019 | 3.08% |
| Dec 31, 2018 | 7.55% |
| Sep 30, 2018 | 6.74% |
| Jun 30, 2018 | 13.81% |
| Mar 31, 2018 | 12.79% |
| Dec 31, 2017 | 24.64% |
| Sep 30, 2017 | 31.26% |
| Jun 30, 2017 | 114.24% |
| Dec 31, 2014 | -97.45% |
| Sep 30, 2014 | -59.00% |
| Jun 30, 2014 | -57.57% |
| Mar 31, 2014 | 131.84% |
| Dec 31, 2013 | -37.00% |
| Sep 30, 2013 | 41.24% |
| Jun 30, 2013 | -34.04% |
| Mar 31, 2013 | -39.01% |
| Dec 31, 2012 | -3.14% |
| Sep 30, 2012 | -32.42% |
| Jun 30, 2012 | -0.04% |